Milestone Scientific (NYSE:MLSS) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of Milestone Scientific (NYSE:MLSS) in a report issued on Wednesday morning. The brokerage issued a hold rating on the stock.

Milestone Scientific Stock Down 1.8 %

Shares of MLSS opened at $0.56 on Wednesday. The company has a 50 day moving average price of $0.65 and a 200-day moving average price of $0.70. Milestone Scientific has a fifty-two week low of $0.52 and a fifty-two week high of $1.35.

Milestone Scientific (NYSE:MLSS) last announced its quarterly earnings results on Friday, March 29th. The company reported ($0.03) earnings per share for the quarter. The business had revenue of $2.26 million during the quarter. Milestone Scientific had a negative return on equity of 86.72% and a negative net margin of 70.50%.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Milestone Scientific stock. AE Wealth Management LLC purchased a new stake in shares of Milestone Scientific Inc. (NYSE:MLSS) during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 27,936 shares of the company’s stock, valued at approximately $26,000. Institutional investors own 5.79% of the company’s stock.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.